case study- peripheral neuropathy (nerve care forum)
TRANSCRIPT
DR SUDHIR KUMAR MD DM
CONSULTANT NEUROLOGIST
APOLLO HOSPITALS, HYDERABAD
Case Study
2
Case StudyPatient presentation
A 49 year old man A Mechanical Engineer by profession, had weakness & wasting of Bilateral hands 6 months back.
History:
Initially noticed – inability to hold any object tightly or extend hand properly.
Followed by wasting of thenar muscles in both hands,
Gradually noticed, difficulty in buttoning shirt & gripping objects tightly,
Noticed tremors of fingers
No h/o of fasciculation
No h/o LL symptoms
No h/o other potential weakness /wasting
No h/o bowel, bladder complaint, no h/o of neck pain
After clinical examination and laboratory diagnosis for Motor Neuron Disease (MND) ????
No conclusion arrived and patient was referred to tertiary care centre.
3
Case StudyEvaluation at tertiary care hospital
Medical history:
Patient noticed thinning of the muscles at base of thumbs approximately since 6-7 months
With disturbed hand writing, needed to apply more force while writing
Can not button/unbutton shirt, can not mix food, cannot hold objects.
Can comb hair, can wash hair, can wear clothes
Physical examination:
Pulse Rate- 86/ min
BP- 150/90 mm of Hg
CNS: Conscious, oriented
Speech- Normal
Pupils- B/L 3mm RTL
EOM- full range
No facial weakness/ sensation normal
Tongue/Palate/ Uvula- Normal
Motor tone Normal
WastingThenar muscle wasting +Fasciculation- Biceps +; Triceps +Ulnar clawing +
4
Case StudyLaboratory investigations
CBC and Electrolytes
Others Urine analysis LFT LIPDS Misc.
Hb- 14TC- 8.89
Vit B12 – 196 Sugar- Nil Proteins- 7.31 TC- 194 S. Ca- 8.7
DC-69.1/23.8/2.4/4.6
TSH- 2.735 Albumin- Nil Albumin- 3.5 HDL- 34 S. PO4- 4.47
FBS- 102 Vit D- 7.10 RBC- 0 Bilirubin- 0.45Direct 0.13
LDL- 142 S. Mg- 1.97
Bu- 19 CPK- 137 WBC- 0 AST- 25 TGL- 116 HCV NegativeANA
Creat- 0.81 CD19- 14.88 ALT- 44 Rheumatoid A-Negative
Na+- 140 CD 20- 17.11 ALP- 71 HBsAg- negative
K+- 4.54 GGT- 39 VDRL- negative
Cl– 103 HIV- negative
ESR- 43 *Autoimmune and Ganglioside IgG antibody tests reports negative
Electrophoresis – Hypoalbuminemia with hyperglobulinemia & increase in alpha 1 & Beta 2 globulins
5
Case studyWhat do you think???
6
Case StudyDiagnosis
1. Bilateral Anterior Horn Disease
2. Vitamin B12 deficiency
3. Vitamin D deficiency
With Hypertension
Advise on discharge:
- Tab Aten (50 mg) 1-0-0
- Tab Meconerve (1500 μg) 1-0-0
- Neuro D3 (60k) Friday
- Tab shelcal (1500) 0-1-0
Follow up with neuro OPD
7
Case StudyCourse of action
While arriving at above diagnosis,
patient was admitted
Evaluated clinically
Autoimmune Paraneoplastic work up sent
Immunofixation & light chain sent
EMG done
Patient discharged along with advise on discharge to follow up with reports in OPD
EMG Report: Median, Ulnar, Peroneal, Tibial, Sural (both UL & LL)- Features suggestive of Severe Motor Axonal Neuropathy in the upper limb’s right › Left.
8
Case StudyDiscussion
Introduction
Peripheral neuropathy is one of the most prevalent neurologic conditions encountered by physicians of allspecialties.
The primary care physician is presented with 3 distinct clinical challenges in caring for patients with peripheral neuropathy:
(1) How to efficiently and effectively screen (in less than 2 minutes) an asymptomatic patient for peripheral neuropathy when they have a disorder in which peripheral neuropathy is highly prevalent(eg, diabetes mellitus),
(2) how to clinically stratify patients presenting with symptoms of neuropathy to determine who would benefit from specialty consultation and what testing is appropriate for those who do not need consultation, and
(3) how to treat the symptoms of painful peripheral neuropathy.
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
9
Case StudyDiscussion
Screening for Peripheral Neuropathy (PN)
The recognition of peripheral neuropathy in patients with disorders, where it is highly prevalent, may affect the management for that disease.
Annual screening for peripheral neuropathy is recommended in diabetic patients
Most recommendations for office screening for neuropathy: light touch perception to a 10-g Semmes-Weinstein monofilament, vibration testing with a 128-Hz tuning fork, superficial pain (pinprick) perception, or testing of ankle deep tendon reflexes
If single-modality screening is used, monofilament light touch or vibration testing appears to be more sensitive and specific than superficial pain (pinprick) or ankle reflex testing.
Importantly, screening is meant to identify whether an asymptomatic patient, at riskfor peripheral neuropathy secondary to a systemic disease, is likely or unlikely tohave a peripheral neuropathy.
Alone, it is insufficient to fully characterize the neuropathy or direct the necessity of
further diagnostic tests or consultations.
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
10
Case StudyDiscussion
EVALUATING PATIENTS PRESENTING WITH CLINICAL SIGNS OR SYMPTOMS SUGGESTING PN
Clinically Stratifying Patients With Peripheral Neuropathy
Evaluation of Length-Dependent Peripheral Neuropathies
Serologic Evaluation
Diabetic Neuropathy
Impaired Glucose Tolerance
Vitamin B12 Deficiency
Dysproteinaemias
Other Laboratory Tests
Toxic Neuropathies
Hereditary Neuropathies
Other Diagnostic Tests Nerve Conduction Studies and Electromyography
Nerve Biopsy
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
11
WHEN TO DO NERVE BIOPSY IN A PATIENT WITH PN?
1. When the neuropathy is progressive,
2. Disease is likely to become disabling or debilitating,
3. Other tests have failed to identify the cause,
4. When a treatable cause is expected (it is better to avoid biopsy, if we are suspecting toxic or diabetic neuropathy)
Sudhir Kumar, Joe Jacob. Neurology India.2004;52:436-8. 12
YIELD OF NERVE BIOPSY IN OUR STUDY
13
Case StudyDiscussion
Regardless of clinical pattern of involvement, patients with acute or subacute onset of symptoms or progressive or functionally limiting neuropathies should be considered for neurologic consultation.
Similarly, clinicians should refer any patient when there is clinical uncertainty.
Neuropathies in Which Specialty Consultation Would Be Beneficial
Acute, Subacute in onset Rapidly progressive Severe, functionally limiting
Length independent (polyradiculoneuropathy)
Multifocal
Motor Predominant
Associated with severe dysautonomia
Regardless of clinical pattern or affected modality
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
14
Case StudyDiscussion
Recommended Evaluation of Chronic Length-Dependent PN
Complete blood cell count
Renal function
Liver function tests
Erythrocyte Sedimentation Rate (extractable nuclear antigen if dry eyes/mouth and sensory neuropathy are present)
Fasting glucose or hemoglobin A1c
Thyroid stimulating hormone
Monoclonal protein (serum protein immunofixation electrophoresis)
Vitamin B12 (with methylmalonic acid)
Infectious (if risk factors or endemic region): Lyme disease, human immunodeficiency virus
Family history of peripheral neuropathy, pes cavus, hammertoes
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
15
Case StudySymptomatic Management of PN
The primary goal in the evaluation of neuropathy:
1. Identify the etiology and if possible treat the underlying cause.
2. However, even when the neuropathy has a treatable etiology (such as diabetes mellitus, vitamin B12 deficiency, or toxic exposure),
3. Treatment serves primarily to prevent further progression of the neuropathic symptoms.
4. In these cases and in those in which the neuropathy is idiopathic or untreatable, management is symptomatic.
One of the most limiting symptoms from peripheral neuropathy is neuropathic pain. Among diabetic patients with neuropathy, 11% to 26% have neuropathic pain. Several consensus algorithms for the treatment of chronic neuropathic pain have
been proposed and compared. Only one has focused explicitly on painful diabetic peripheral neuropathy.
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
Title of Presentation | DD.MM.YYYY16
17
Case StudyConclusion
Peripheral neuropathy is commonly encountered in the primary care setting.
In patients with systemic disease such as diabetes mellitus, peripheral neuropathy can be efficiently identifiedor ruled out by screening with a combination of vibration and light touch testing.
Most peripheral neuropathies are length dependent, sensory predominant, and clinically mild to moderate inseverity without notable functional limitations.
These neuropathies can usually be effectively worked up and managed without specialty consultation.
The highest-yield screening is for diabetes mellitus, vitamin B12 with methylmalonic acid, serum protein electrophoresis, and family history suggesting an inherited neuropathy.
Neuropathies that are length independent (polyradiculoneuropathies), multifocal, severe, functionally limiting, orrapidly progressive warrant neurologic consultation.
Neuropathic pain can be effectively treated with an algorithmic approach.
James C. Watson, and P. James B. Dyck, Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management. 2015, Mayo Clin Proc. 90(7):940-951
18
COMMENTS/QUERIES?